151 results
Page 4 of 8
424B3
9am6r i944g2
13 Aug 21
Prospectus supplement
5:25pm
424B3
tmd983 hd76
5 Aug 21
Prospectus supplement
4:26pm
8-K
EX-10.2
7a2g4i98l7gdr1ixj
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.3
1fuxq0c8
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
3y5up3q 431
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-16.1
56nqz9il
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-99.1
0ewuvudh
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-3.2
ebhk2 nwh0tc
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-3.1
ajc3be9gd1h108p safl
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.18
01w2r fqsyr8vube3gq
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
56yi21
30 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am
424B3
7xwz9do4l
9 Jun 21
Prospectus supplement
4:42pm
8-K
EX-99.1
iqx08q0d3idpqv
9 Jun 21
Other Events
4:40pm
425
EX-99.1
gz9yx0hcfucnzi6u
9 Jun 21
Business combination disclosure
4:38pm
8-K
EX-99.1
d3eqrkw
4 Jun 21
POINT Biopharma Announces First Patients
4:22pm
425
EX-99.1
mck8as1kh 80zip
4 Jun 21
Business combination disclosure
4:20pm
8-K
EX-99.1
l2jdis3ofpjb 99jz
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm